Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Potent and selective 20-HETE synthase inhibitors under study at Taisho

April 2, 2001

Novel alpha1A/1B-adrenoceptor antagonists and use in BPH and pain

March 29, 2001

Sildenafil shows good cardiovascular safety and beneficial effects on exercise capacity

March 28, 2001

Abbott discovers new potassium channel openers useful for bladder overactivity, etc.

March 26, 2001

OPC-51803, a new vasopressin V2 agonist, characterized in dogs

March 23, 2001

Uroselective alpha1-adrenoceptor antagonists under study at Recordati

March 22, 2001

Vernalis to clinically evaluate VML-670 for sexual dysfunction

March 19, 2001

Shire seeks E.U. approval of Foznol

March 15, 2001

Preliminary U.S. testing of Alprox-TD in severe ED patients completed

March 14, 2001

Fujisawa claims cGMP-PDE inhibitors particularly useful for erectile dysfunction Rx

March 12, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...